Related Experiment Video
Updated: Jun 23, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 1, 2010
Oestrogen inhibits human colonic motility by a non-genomic cell membrane receptor-dependent mechanism
A M Hogan1, R Kennelly, D Collins
1Institute for Clinical Outcomes Research and Education, St Vincent's University Hospital, Dublin, Ireland.
Background:
Classical effects of oestrogen involve activation of target genes after binding nuclear receptors. Oestrogenic effects too rapid for DNA transcription (non-genomic) are known to occur. The effect of oestrogen on colonic motility is unknown despite the prevalence of gastrointestinal symptoms in pregnant and premenopausal women.
Methods:
Histologically normal colon was obtained from proximal resection margins of colorectal carcinoma specimens. Circular smooth muscle strips were microdissected and suspended in organ baths under 1 g of tension. After equilibration, they were exposed to 17beta-oestradiol (n = 8) or bovine serum albumin (BSA)-conjugated 17beta-oestradiol (n = 8). Fulvestrant, an oestrogen receptor antagonist, was added to some baths (n = 8). Other strips were exposed to calphostin C or cycloheximide. Carbachol was added in increasing concentrations and contractile activity was recorded isometrically.
Results:
Oestrogen inhibited colonic contractility (mean difference 19.7 per cent; n = 8, P < 0.001). In keeping with non-genomic, rapid-onset steroid action, the effect was apparent within minutes and reversible. It was observed with both 17beta-oestradiol and BSA-conjugated oestrogen, and was not altered by cycloheximide. Effects were inhibited by fulvestrant, suggesting receptor mediation.
Conclusion:
Oestrogen decreases contractility in human colonic smooth muscle by a non-genomic mechanism involving cell membrane coupling.
Insights
Oestrogen significantly reduces human colon muscle contractions through a rapid, non-genomic pathway. This finding may explain gastrointestinal symptoms in women related to oestrogen levels.
Area of Science:
- Endocrinology
- Gastroenterology
- Pharmacology
Background:
- Classical oestrogen effects involve nuclear receptor binding and gene activation.
- Rapid, non-genomic oestrogenic effects bypassing DNA transcription are known.
- The impact of oestrogen on colonic motility remains largely uncharacterized.
Purpose of the Study:
- To investigate the effect of oestrogen on human colonic smooth muscle contractility.
- To determine if the effect is genomic or non-genomic.
- To explore the mechanism of oestrogen action on the colon.
Main Methods:
- Human colon smooth muscle strips were isolated and mounted in organ baths.
- Strips were exposed to 17beta-oestradiol or BSA-conjugated 17beta-oestradiol.
- Contractile responses to carbachol were measured in the presence or absence of oestrogen receptor antagonist (fulvestrant) or protein synthesis inhibitors.
Main Results:
- Oestrogen significantly inhibited colonic smooth muscle contractility (P < 0.001).
- The inhibitory effect was rapid, reversible, and occurred with both forms of oestrogen.
- The effect was not altered by cycloheximide but was inhibited by fulvestrant, indicating receptor mediation.
Conclusions:
- Oestrogen decreases contractility in human colonic smooth muscle.
- The mechanism is non-genomic, involving cell membrane coupling.
- This rapid action suggests a role for oestrogen in modulating colonic motility.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
08:02Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
Published on: March 12, 2020
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Oogenesis
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...